Highlights:
- A myriad of late-breaking study results presented at the 2026 International Stroke Conference (ISC; 4–6 February, New Orleans, USA), including breakthrough findings on medium-vessel occlusion (MeVO) stroke thrombectomy from the ORIENTAL MEVO and DISTALS trials
- A closer look at the neurointerventional community’s reaction to long-awaited findings from the international CREST-2 study
- The potential role for simulation-based training within the expansion of middle meningeal artery embolisation (MMAe) treatments for chronic subdural haematoma (cSDH)
- New American Stroke Association (ASA) guidelines attempting to expand eligibility for advanced therapies while also providing a “major step” towards standardised, evidence-based care in paediatric stroke patients
- PROFILE: David Liebeskind (Los Angeles, USA)
